A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer

NCT06202261 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer
Recurrent Breast Cancer
Advanced Malignancies

Interventions

DRUG: TQB2930 for injection
DRUG: Paclitaxel for injection (albumin-bound)
DRUG: TQB3616 capsule
DRUG: Fulvestrant injection
DRUG: Capecitabine tablets
DRUG: Vinorelbine tartrate injection
DRUG: Eribulin mesylate injection
DRUG: gemcitabine hydrochloride for injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.